601607:SHA
Shanghai Pharmaceuticals Holding Ord Shs A
CNÂ¥16.62
arrow_upward
+1.09%(+0.18) 1D
Sep 4, 3:00:01 PM GMT+8 · CNY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 601607...
Open
CNÂ¥16.43
High
CNÂ¥16.68
Low
CNÂ¥16.40
Mkt. cap
54.60B
Avg. vol.
11.89M
Volume
10.22M
Dividend
2.83%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Jul 17, 2026
P/E ratio
12.91
52-wk high
CNÂ¥18.56
52-wk low
CNÂ¥15.01
EPS
CNÂ¥1.29
Shares outstanding
1.92B
No. of employees
49K
Open
CNÂ¥16.43
High
CNÂ¥16.68
Low
CNÂ¥16.40
Mkt. cap
54.60B
Avg. vol.
11.89M
Volume
10.22M
Dividend
2.83%
Quarterly dividend
CNÂ¥0.12
Ex-dividend date
Jul 17, 2026
P/E ratio
12.91
52-wk high
CNÂ¥18.56
52-wk low
CNÂ¥15.01
EPS
CNÂ¥1.29
Shares outstanding
1.92B
No. of employees
49K
Related stocks
Profile
Shanghai Pharmaceuticals is a private-sector Chinese pharmaceutical company. The organization develops and distributes pharmaceutical products and operates in domestic and international markets.
Shanghai Pharma is the largest pharmaceutical and the first A+H listed company in China to be dual-listed by Shanghai and Hong Kong Stock Exchanges. As of 2020, the company made its presence to the Global Fortune 500 list with the ranking of 473, overall and 124 among 21 other Chinese companies on the list.
Shanghai Pharmaceuticals was founded in 1994 and is headquartered in Shanghai. As an investment holding company, it is actively engaged in research, manufacturing and distribution of pharmaceutical and healthcare products in China, that develops and distributes traditional Chinese and chemical drugs, chemical, biochemical and healthcare goods that are applied in various therapeutic fields, including immunoregulation and anti-cancer, immune system and digestion, cardiovascular and anti-infection, nervous system and mental disorder. Wikipedia
About Shanghai Pharmaceuticals Holding Ord Shs A